When we come across a seriously attractive investment opportunity, we must not get into a decision making paralysis. Instead, we must buy first and think later says Rakesh Jhunjhunwala
Subscribe to Blog via Email
Join 509 other subscribers
- Raymond Lifestyle has multiple growth drivers. Target Price ₹3000 (+49%)Raymond Lifestyle has multiple growth drivers. It boasts legacy of established brands such as Park Avenue. However brands remain under-penetrated due to sluggish execution in past. Renewed focus on growth could lead to valuation re-rating. TP ₹3000 (+49%) Download research report... Raymond Lifestyle has multiple growth drivers. Target Price ₹3000 (+49%)
- Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 CrSunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr. M-Cap is ₹5800 Cr. Promoters hold 46%. Co operates in 3 areas i.e. Xanthine derivatives, API & CDMO/CMO. It is largest Indian manufacturer of Xanthines & has Global market share of 15-20% ... Sunil Singhania's Abakkus has bought 10.69L shares […]
- PNB Housing is undergoing a transformation to morph into a franchise that will be strongerPNB Housing is undergoing a transformation to morph into a franchise that will be stronger, more resilient & with high predictability in earnings trajectory. Risk-reward profile is favorable for a long-term investor. Buy for TP of ₹1160 (38% upside) Download research... PNB Housing is undergoing a transformation to morph into a franchise that will be […]
Recent Posts
- Raymond Lifestyle has multiple growth drivers in place. Buy for target price of ₹3000 (49% upside): Motilal Oswal
- PNB Housing is a strengthening franchise where the risk-reward profile is favorable for a long-term investor. Buy for target price of ₹1160 (38% upside): Motilal Oswal
- Piramal Pharma is seeing strong momentum in CDMO. Buy for target price f ₹320 (27% upside): ICICI Direct
- Hiren Ved has no Banking stocks in his portfolio. Ravi Dharamshi is very bullish about energy transition
- Protean eGov Technologies is a unique play on digital public infrastructure. Buy for target price of ₹2510 (24% upside): ICICI Direct
Recent Comments